Top Markets
Coin of the day
PreveCeutical Medical Inc. PreveCeutical Medical Inc.

PreveCeutical Medical Inc.

PREV
Rang in Aktien #33932
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating... PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
Aktienkurs
$0.01100905
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$6.59M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-49.29%
Land
CA
Handel PreveCeutical Medical Inc. (PREV)

Kategorie

Dividendenrendite-Verlauf für PreveCeutical Medical Inc. (PREV)
Dividendenrendite (TTM) von PreveCeutical Medical Inc. (Aktienkürzel: PREV) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für PreveCeutical Medical Inc. (PREV) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber